Insights On Drug Development

  1. Stability Screening For Colloidal Stability: Diffusion Interaction Parameter Thermal Shift Assay 4/28/2025

    Colloidal stability is one of the most important properties to control due to the propensity for biopharmaceuticals to aggregate and the subsequent potential to severely affect the drug's efficacy and patient safety.

  2. Why Cell Line Screening Is Crucial For Successful CDC Assay Development 4/28/2025
  3. Accelerated Tox Offerings: A Recipe For Streamlining IND Applications 4/22/2025

    Accelerating the timeline to tox material can significantly enhance the drug development process, enabling faster IND submissions and providing crucial time savings for toxicology studies.

  4. Early-Phase Whole-Body PK 4/21/2025

    Accelerate your path to the clinic with Aliri’s cost-effective, label-free whole-body PK service — designed to deliver deeper insights, faster decisions, and better outcomes for your drug candidates.

  5. Label-Free Whole-Body Pharmacokinetics 4/21/2025

    This approach enables tissue-level analysis, delivering insights into efficacy at the site of action, uncovering potential safety concerns, and supporting smarter clinical candidate selection.

  6. Time: A Crucial Factor In Therapeutics Development 4/21/2025

    Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.

  7. Enabling mRNA Therapeutic Development Through Enhanced IVT Capping Efficiency 4/16/2025

    See how Codex HiCap RNA Polymerase supports the production of high-performance synthetic mRNA, paving the way for next-generation mRNA therapies.

  8. Challenges In ADC Production - Consolidating Operations Under One Roof 4/15/2025

    Eurofins CDMO Alphora consolidates ADC development and manufacturing under one roof, streamlining processes, enhancing safety, and accelerating delivery of high-quality, clinically-ready antibody-drug conjugates.

  9. Surface Plasmon Resonance for Biomolecular Interaction Analysis 4/15/2025

    Explore how uncovering molecular interactions can drive breakthroughs in disease understanding, drug discovery, and therapeutic innovation.

  10. A New Paradigm In T-Cell Lymphoma Treatment: CD5 CAR-NK 4/14/2025

    T-cell lymphomas are a complex and increasingly prevalent group of cancers with poor survival outcomes and limited effective treatments, underscoring an urgent need for innovative therapies and novel targets.